Mots-C
Mots-C
MOTS-c is a unique peptide encoded within the mitochondrial genome itself, functioning as a systemic metabolic signal that instructs the body on energy regulation. Research demonstrates it activates the AMPK pathway in skeletal muscle, enhancing glucose uptake and insulin sensitivity. Human studies show that circulating MOTS-c declines with age and correlates with metabolic fitness — and that exercise elevates MOTS-c levels within 30 minutes, suggesting it mediates key metabolic benefits of physical activity.
Supplied as research-grade lyophilised peptide. Requires reconstitution with bacteriostatic water prior to use. For research purposes only.
Research Stack Builder
Build Your Research Stack
Curated combinations based on what researchers actually stack — backed by published data, priced to save.
Stack with Mots-C
Why researchers stack these
- 01Parallel mitochondrial decline — combined restoration
- 02GH axis complements AMPK mechanism
- 03Structural repair completes the protocol
Full research context
MOTS-c activates AMPK in skeletal muscle, drives insulin sensitivity, and acts as a retrograde mitochondrial signal to the nucleus — influencing nuclear gene expression. NAD+ restores sirtuin and PARP function and declines alongside MOTS-c with age; their combined restoration is among the most researched longevity interventions. Tesamorelin adds the GH axis component for visceral fat targeting — mechanistically distinct from AMPK signalling. GHK-Cu provides the structural repair layer: collagen synthesis and gene modulation that metabolic protocols benefit from.
Recovery & Repair Protocol
The most studied peptide combination for tissue repair, injury recovery & musculoskeletal healing
Why researchers stack these
- 01Non-competing structural repair pathways
- 02BPC-157 angiogenesis + TB-500 satellite cell activation
- 03GHK-Cu adds the extracellular matrix layer both lack
Full research context
BPC-157 and TB-500 are the two most frequently co-researched repair peptides in published literature, acting through complementary mechanisms — BPC-157 via nitric oxide pathways and angiogenesis, TB-500 via actin-sequestering and satellite cell activation. GHK-Cu rounds out the stack by supporting collagen synthesis and the extracellular matrix that both compounds do not directly address, while reducing the oxidative load that slows tissue recovery.
Metabolic & Body Recomposition
Most popular Peptide Pal stack — two non-competing fat loss axes with skin integrity support
Why researchers stack these
- 01GLP-1 triple agonism + GH axis — two distinct fat loss pathways
- 02Skin integrity preserved throughout recomposition
- 03Most purchased together on Peptide Pal
Full research context
Retatrutide and Tesamorelin address body composition through two non-competing mechanisms. Retatrutide's triple receptor agonism drives broad metabolic improvement and appetite regulation; Tesamorelin is FDA-approved for visceral adipose reduction through the growth hormone axis — a distinct mechanism. GHK-Cu supports skin integrity during recomposition; rapid fat loss without collagen support produces visible skin laxity that is far harder to address after the fact.
Cognitive Performance Stack
Neuropeptides studied for synergistic cognitive enhancement, focus & stress resilience — no sedation
Why researchers stack these
- 01BDNF stimulation balanced by GABA modulation
- 02Focus without anxiety — three non-competing pathways
- 03NAD+ fuels the neuronal energy demand
Full research context
Semax and Selank are registered pharmaceuticals with distinct mechanisms. Semax drives BDNF upregulation and cortical processing speed; Selank reduces the stress-induced cognitive interference that can blunt that effect, without sedation or dependency. NAD+ provides the cellular energy substrate that enhanced neuronal activity demands — researchers consistently report that this combination delivers balanced cognitive performance that neither compound achieves alone.
Skin & Glow Protocol
Collagen synthesis, antioxidant protection & melanin research in one comprehensive skin stack
Why researchers stack these
- 01Collagen, antioxidant & pigmentation — three skin pillars
- 02Tyrosinase inhibition counterbalances MC1R agonism for pathway research
- 03Structural integrity maintained alongside brightening
Full research context
GHK-Cu stimulates collagen synthesis and modulates over 4,000 genes involved in skin repair and inflammatory control — addressing the structural layer. Glutathione reduces oxidative stress and inhibits tyrosinase, producing measurable skin brightening with 30–35% tissue GSH increases confirmed in human RCTs. MT2 drives eumelanin synthesis via MC1R agonism, and researchers frequently combine it with Glutathione to study the interplay between melanocortin-driven pigmentation and tyrosinase inhibition simultaneously. Together these three represent the most comprehensive skin research protocol available.
Cellular Longevity Protocol
Three compounds that decline together with age — combined restoration for mitochondrial & cellular health
Why researchers stack these
- 01All three decline together with age — parallel restoration
- 02Mitochondrial energy, AMPK signalling & antioxidant protection
- 03Most complete cellular longevity protocol available
Full research context
NAD+, MOTS-c, and glutathione all decline measurably with age through parallel but distinct pathways. NAD+ restores sirtuin and PARP function essential for mitochondrial biogenesis and DNA repair — declining up to 50% by age 60. MOTS-c is the mitochondria-derived peptide that activates AMPK signalling and declines alongside NAD+; their combined restoration is the most researched longevity intervention. Glutathione provides the antioxidant protection that prevents cellular damage during the heightened metabolic activity that NAD+ and MOTS-c restoration drives — completing what researchers describe as the foundational cellular longevity triad.
Research & Studies
Peer-reviewed research supporting Mots-C
MOTS-c Circulating Levels Decline with Age and Correlate with Metabolic Health in Human Subjects
Researchers at the USC Leonard Davis School of Gerontology characterised MOTS-c as a detectable peptide in human blood circulation and demonstrated a significant age-dependent decline in circulating MOTS-c concentrations in older adults compared to younger controls. Physically active individuals with high metabolic fitness maintained significantly elevated plasma MOTS-c versus sedentary age-matched participants, with MOTS-c concentrations correlating positively with skeletal muscle insulin sensitivity and markers of mitochondrial biogenesis. An acute exercise intervention confirmed that plasma MOTS-c rises measurably within 30 minutes in human participants, establishing MOTS-c as an exercise-mimicking mitochondrial hormone with direct relevance to human metabolic health.
MOTS-c: Mitochondrial-Derived Peptide Regulation of Insulin Sensitivity and Metabolic Homeostasis
MOTS-c was identified as a 16-amino acid peptide encoded in the mitochondrial 12S rRNA gene, acting as a systemic hormonal signal that regulates metabolic homeostasis. Administration significantly reduced obesity, improved insulin sensitivity, and countered diet-induced glucose intolerance by activating the AMPK pathway in skeletal muscle, enhancing glucose uptake and fatty acid oxidation. Subsequent research demonstrated that MOTS-c translocates to the cell nucleus under metabolic stress to regulate adaptive nuclear gene expression, establishing it as the first mitochondria-to-nucleus retrograde signal peptide with direct therapeutic implications for insulin resistance and metabolic disease.